Life Sciences Industry News
-
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses…
-
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce…
-
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block…
-
SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in…
-
Gentex Announces New Nanofiber Sensing Technology
Press Release Courtesy of Gentex ZEELAND, Mich., Jan. 12, 2021 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX) today announced the acquisition of a…
-
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly…
-
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update
Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”)…
-
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita
Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression…
-
Early Vaccination Available for Some Life Science Industry Employees
We’ve received more information on channels for vaccine distribution with some positive developments
-
Vertex Announces FDA Approvals for Expanded Use of Cystic Fibrosis Medicines
Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF)…
-
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced…
-
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
Article courtesy of Business Wire December 21, 2020 10:00 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Phoenix PharmaLabs,…
-
Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test
Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers…
-
ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark
ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The…
-
IONIQ Sciences Designated ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine
12/10/2020 – IONIQ Sciences has been designated as 2020’s ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV…
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in the Dubermatinib Arm of The Leukemia & Lymphoma Society’s Beat AML Master Clinical Trial in Patients with Acute Myeloid Leukemia
Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been…
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 2 of Cancer Study
Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been…
-
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing…
-
Braveheart Brings Healthcare to India’s Last Mile Community
These days we can all use uplifting news, so please check out this short story about how BraveHeart…
-
Who’s First In Line for the COVID Vaccine? CDC’s Immunization Advisory Committee Makes Recommendations
With the first shipments of the Pfizer/BioNTech vaccine scheduled to arrive in a matter of weeks and Moderna…
-
Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity
The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge…
-
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance
Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
BioHive Launched at Utah Life Sciences Summit – Join the Campaign
The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the…
-
Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific…
-
BioUtah Launches BioHive Initiative to Promote Utah’s Life Sciences Industry
Article courtesy of BusinessWire Local leaders to create ecosystem for innovation, job creation, and growth SALT LAKE CITY–(BUSINESS…
-
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement…
-
Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research
Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic…
-
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors
CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today…
-
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…
-
Xenocor Granted Breakthrough Technology Agreement with Premier Inc.
Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY,…
-
Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor
For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October…
-
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives
Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized…
-
Foldax Named Finalist in the Fierce Innovation Awards
Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020,…
-
Alucent Biomedical Announces $35 Million Series B Financing
Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is…
-
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the…
-
Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday…
-
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response
Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
